Charles Schwab’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.24M | Sell |
930,877
-19,870
| -2% | -$47.9K | ﹤0.01% | 2629 |
|
|
2025
Q1 | $2.1M | Buy |
950,747
+44,258
| +5% | +$97.8K | ﹤0.01% | 2601 |
|
|
2024
Q4 | $4.94M | Sell |
906,489
-40,087
| -4% | -$218K | ﹤0.01% | 2339 |
|
|
2024
Q3 | $7.87M | Buy |
946,576
+56,071
| +6% | +$466K | ﹤0.01% | 2153 |
|
|
2024
Q2 | $6.38M | Buy |
890,505
+248,042
| +39% | +$1.78M | ﹤0.01% | 2245 |
|
|
2024
Q1 | $5.57M | Buy |
642,463
+79,789
| +14% | +$692K | ﹤0.01% | 2242 |
|
|
2023
Q4 | $3.69M | Sell |
562,674
-47,512
| -8% | -$311K | ﹤0.01% | 2432 |
|
|
2023
Q3 | $6.1M | Buy |
610,186
+24,927
| +4% | +$249K | ﹤0.01% | 2162 |
|
|
2023
Q2 | $7.27M | Buy |
585,259
+6,804
| +1% | +$84.6K | ﹤0.01% | 2060 |
|
|
2023
Q1 | $8.1M | Sell |
578,455
-1,954
| -0.3% | -$27.4K | ﹤0.01% | 1971 |
|
|
2022
Q4 | $8.31M | Buy |
580,409
+13,602
| +2% | +$195K | ﹤0.01% | 1968 |
|
|
2022
Q3 | $14.5M | Sell |
566,807
-23,519
| -4% | -$600K | 0.01% | 1607 |
|
|
2022
Q2 | $16.8M | Sell |
590,326
-12,845
| -2% | -$365K | 0.01% | 1530 |
|
|
2022
Q1 | $21.3M | Buy |
603,171
+14,732
| +3% | +$520K | 0.01% | 1490 |
|
|
2021
Q4 | $24.7M | Buy |
588,439
+13,227
| +2% | +$554K | 0.01% | 1409 |
|
|
2021
Q3 | $28.2M | Buy |
575,212
+101,825
| +22% | +$5M | 0.01% | 1286 |
|
|
2021
Q2 | $19.8M | Buy |
473,387
+167,826
| +55% | +$7M | 0.01% | 1600 |
|
|
2021
Q1 | $10.9M | Buy |
+305,561
| New | +$10.9M | ﹤0.01% | 1913 |
|